P
Peter D. Schellinger
Researcher at Ruhr University Bochum
Publications - 262
Citations - 18189
Peter D. Schellinger is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 64, co-authored 240 publications receiving 15911 citations. Previous affiliations of Peter D. Schellinger include University Hospitals of the Ruhr-University of Bochum & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Current acute stroke trials and their potential impact on the therapeutic time window.
TL;DR: This perspective will cover the recently completed and currently recruiting acute stroke trials with respect to their potential role in expanding the therapeutic time window for acute ischemic stroke.
Journal ArticleDOI
Patient selection for thrombolysis using perfusion and diffusion MRI. An overview
TL;DR: MRI-based thrombolysis can be performed after 3 h based on individual benefit:risk assessment in experienced stroke centers, and reperfusion unequivocally as an important predictor of the clinical response to throm bolysis is identified.
Journal ArticleDOI
The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
TL;DR: This review reports on the currently available literature on heparins for the reduction of stroke-related morbidity and mortality, the prevention of recurrent stroke as well as the Prevention of venous thromboembolism in both ischaemic and haemorrhagic stroke with respect to their risks.
Journal ArticleDOI
Intravenous thrombolysis in patients with acute ischaemic stroke with history of prior ischaemic stroke within 3 months
Georgios Tsivgoulis,Aristeidis H. Katsanos,Peter D. Schellinger,Martin Köhrmann,Thorsten Steiner,Valeria Caso,Lina Palaiodimou,Daniel Strbian,Niaz Ahmed,Andrei V. Alexandrov,Sean I Savitz +10 more
TL;DR: This systematic review and meta-analysis sought to compare the safety and efficacy of IVT treatment between patients with AIS with a history of previous ischaemic stroke within 3 months and patients withAIS but without ahistory of previous IS within3 months from the index event.
Journal ArticleDOI
Malignant hyperthermia and its differential diagnosis
TL;DR: Sign and symptoms, pathophysiology and therapeutic options of the three most common hyperthermic syndromes in neurology: malignant hyperthermia, serotonine-syndrom and malignant neuroleptic syndrome are illustrated to enable the reader to make the differential diagnosis of these three disease entities.